Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 39 matching records.
39 results — page 1 of 2
- Level BRandomized Controlled TrialPubMed
Safety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review.
Randomized Controlled Trial on Systemic / IV, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther3 citations - Level ASystematic ReviewPubMed
A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia.
Systematic Review with a reported sample of 724 on Hair Loss, Hair Regeneration, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 724
Stem Cell Res Ther - Level BClinical TrialEurope PMC
An open phase I/IIa study evaluating safety, patient-reported outcomes and voice function after surgery, local administration of mesenchymal stromal cells and voice training in patients with vocal fold scarring and dysph
Clinical Trial on Scar, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialPubMed
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II Trial.
Clinical Trial, published in Clin Cancer Res (2025) — summary generated from the PubMed abstract.
- 2025
Clin Cancer Res3 citations - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level BClinical TrialEurope PMC
Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trial
Clinical Trial on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level CProspective StudyPubMed
Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoar
Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Dev (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cells Dev5 citations - Level BClinical TrialPubMed
Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 1: current logistics and safety.
Clinical Trial, published in J Am Vet Med Assoc (2024) — summary generated from the PubMed abstract.
- 2024
J Am Vet Med Assoc - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level BClinical TrialPubMed
The investigation and comparison of the efficacy and safety of stromal vascular fraction (SVF), platelet rich plasma (PRP), and 1064-nm Q-switched Nd:YAG laser in reducing nanofat treated infraorbital dark circles and wr
Clinical Trial with a reported sample of 15 on Skin Aging, published in Skin Res Technol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 15
Skin Res Technol5 citations - Level BClinical TrialPubMed
Safety of adipose-derived stromal vascular fraction cells to treat Parkinson's disease.
Clinical Trial with a reported sample of 9 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Parkinsonism Relat Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 9
Parkinsonism Relat Disord2 citations - Level BClinical TrialPubMed
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy).
Clinical Trial with a reported sample of 18 on Chronic Kidney Disease, published in Stem Cells Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 18
Stem Cells Transl Med8 citations - Level BClinical TrialPubMed
Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial.
Clinical Trial with a reported sample of 8 on Scar, published in Am J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
- n = 8
Am J Stem Cells5 citations - Level BClinical TrialPubMed
Long-Term Safety of Bone Regeneration Using Autologous Stromal Vascular Fraction and Calcium Phosphate Ceramics: A 10-Year Prospective Cohort Study.
Clinical Trial with a reported sample of 5, published in Stem Cells Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 5
Stem Cells Transl Med6 citations - Level BClinical TrialPubMed
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial.
Clinical Trial on Neuroinflammation, published in Gen Psychiatr (2023) — summary generated from the PubMed abstract.
- 2023
Gen Psychiatr - Level BClinical TrialPubMed
Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial.
Clinical Trial on Back Pain, Disc Degeneration, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level CCohort StudyPubMed
Clinical Safety and Effectiveness of Adipose-Derived Stromal Cell vs Stromal Vascular Fraction Injection for Treatment of Knee Osteoarthritis: 2-Year Results of Parallel Single-Arm Trials.
Cohort Study with a reported sample of 80 on Knee Osteoarthritis, Osteoarthritis, published in Am J Sports Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 80
Am J Sports Med24 citations - Level BClinical TrialPubMed
The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial.
Clinical Trial with a reported sample of 7 on Scar, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
- n = 7
Stem Cell Res Ther32 citations - Level DAnimal StudyPubMed
Bioscaffold developed with decellularized human amniotic membrane seeded with mesenchymal stromal cells: assessment of efficacy and safety profiles in a second-degree burn preclinical model.
Animal Study on Chronic Wound, Burns, published in Biofabrication (2022) — summary generated from the PubMed abstract.
- 2022
Biofabrication8 citations - Level BClinical TrialPubMed
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, pha
Clinical Trial with a reported sample of 3 on Hair & Scalp, published in J Ovarian Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 3
J Ovarian Res59 citations - Level BClinical TrialPubMed
The efficacy and safety of autologous stromal vascular fraction transplantation for infraorbital skin rejuvenation: A clinical prospective study.
Clinical Trial on Skin Aging, published in J Cosmet Dermatol (2021) — summary generated from the PubMed abstract.
- 2021
J Cosmet Dermatol8 citations - Level BClinical TrialPubMed
Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year.
Clinical Trial with a reported sample of 51 on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
- 2021
- n = 51
Stem Cells Transl Med54 citations - Level BClinical TrialPubMed
Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.
Clinical Trial, published in J Extracell Vesicles (2021) — summary generated from the PubMed abstract.
- 2021
J Extracell Vesicles - Level BClinical TrialPubMed
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Clinical Trial with a reported sample of 17 on Neuroinflammation, published in Cell J (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Cell J7 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406